Clinical trials
Breast Neoplasms trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Active, not recruiting | 14 |
| Recruiting | 13 |
| Terminated | 8 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 11 |
| Hoffmann-La Roche | 9 |
| AstraZeneca | 8 |
| Novartis Pharmaceuticals | 8 |
| Norwegian University of Science and Technology | 6 |
| Norwegian Institute of Public Health | 5 |
| St. Olavs Hospital | 4 |
| Bayer | 3 |
| Haukeland University Hospital | 3 |
| Sykehuset Telemark | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 99 |
| Neoplasms | 10 |
| Neoplasm Metastasis | 7 |
| Prostatic Neoplasms | 5 |
| Fatigue | 4 |
| Melanoma | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Breast Diseases | 3 |
| Heart Failure | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 51 to 75 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.